Skip to main content

POET Technologies Provides Purchase Order Update

SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced the cancellation of all purchase orders received by the Company from Celestial AI, including the ones for initial production units first disclosed (the “Purchase Orders”) by the Company in a press release on April 25, 2023. Marvell Semiconductor Inc., which acquired Celestial AI, provided written notice of the cancellation to the Company on April 23, 2026. As the basis for the cancellation, Marvell indicated that the Company had made disclosures of information related to the Purchase Order and shipping information in contravention...

Continue reading

Telos Corporation to Announce First Quarter 2026 Financial Results on May 11, 2026

ASHBURN, Va., April 27, 2026 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it will report first quarter 2026 financial results on Monday, May 11, 2026. Management will host a webcast to discuss the Company’s financial results and business outlook at 9:30 a.m. ET.What: Telos Corporation First Quarter 2026 Financial Results WebcastWhen: Monday, May 11, 2026Time: 9:30 a.m. ETWebcast: https://investors.telos.com/news-and-events/events   An on-demand replay of the webcast will be available on the Company’s investor relations website. About Telos CorporationTelos Corporation (NASDAQ: TLS) empowers and protects the world’s most security-conscious organizations with efficient,...

Continue reading

Getty Images Selected as Official Photographer of 2026 Met Gala

A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, has once again been named the Official Photographer of The Metropolitan Museum of Art’s Costume Institute Benefit, more commonly known as The Met Gala. Taking place on May 4, fashion’s most prestigious event will bring together icons from the world of fashion, film, music, sports, business and art. Getty Images’ award-winning entertainment photographers and videographers will deliver unparalleled coverage of the invitation-only event for the eighth consecutive year. Employing remote cameras and a mobile film studio, the team will capture every angle – from red carpet arrivals and departures to candid images inside...

Continue reading

Critical Metals to Acquire European Lithium

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical mineral mining company, today announced the signing of a letter of intent whereby Critical Metals has proposed to acquire all of the outstanding shares of European Lithium Ltd. (ASX: EUR) (“European Lithium”) (the “Proposed Transaction”). Under the Proposed Transaction, European Lithium shareholders will receive 0.035 shares of Critical Metals for each European Lithium share held (the “Exchange Ratio”). Based on the Exchange Ratio and considering the unaffected closing price of Critical Metals and the US Dollar to Australian Dollar exchange rate on April 22, 2026 (the “Measurement Date”), the total aggregate consideration payable to European Lithium equity holders is approximately...

Continue reading

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program

Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04’s role in providing a treatment option for patients where existing treatments inadequately address patient outcomes GLEN ALLEN, Va., April 27, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the submission of the AD04 product application for consideration of the Food & Drug Administration (FDA) Commissioner’s National Priority Voucher Pilot Program (CNPV). Announced in 2025, the CNPV program is designed to speed up the FDA review process for drugs that address one of five key U.S. national health...

Continue reading

TeaPot® Declares Second Saturday in May “Take Your Mom to the Dispensary Day”

Cannabis iced tea brand is celebrating mom and launching new THC-infused raspberry black teaTeaPot is celebrating mom and launching new THC-infused raspberry black teaTeaPot Extra Raspberry Black Tea is made with real black tea and infused with 10mg of Live Rosin THC and 10mg of CBG – “the mother of all cannabinoids.”TeaPot declares second Saturday in May “Take Your Mom to the Dispensary Day”Take Your Mom to The Dispensary on May 9, 2026Toronto, April 27, 2026 (GLOBE NEWSWIRE) — Fresh off 4/20, TeaPot®, the award-winning cannabis-infused iced tea brand from The Boston Beer Company’s Canadian-based subsidiary (BBCCC, Inc.) declares a new holiday worth celebrating: Take Your Mom to the Dispensary Day. Since cannabis was legalized in Canada in 2018, consumption by older adults has risen more rapidly than any other...

Continue reading

Gaia Sets First Quarter 2026 Conference Call for Monday, May 4, 2026, at 4:30 p.m. ET

BOULDER, Colo., April 27, 2026 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), the world’s largest conscious streaming platform with 10,000 videos dedicated to health, wellness and spiritual growth, will conduct a conference call on Monday, May 4, 2026, at 4:30 p.m. Eastern time (2:30 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2026. The company will report its financial results in a press release prior to the call. Gaia management will host the conference call, followed by a question and answer period. Date: Monday, May 4, 2026Time: 4:30 p.m. Eastern time (2:30 p.m. Mountain time)Toll-free dial-in number: 1-877-269-7751International dial-in number: 1-201-389-0908Conference ID: 13759800 Please call the conference telephone number 5-10 minutes prior to the start time. An operator...

Continue reading

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BI7676b33322324840ad2b154cc8e65b88. Once registered, a dial-in number, unique pin, and instructions will be provided to participants. The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following...

Continue reading

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026

Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional Presentations at ASGCT Showcase Tenaya’s Work with Patients to Advance Gene Therapy and Early-Stage Pipeline Innovations in Cardiac Gene Editing SOUTH SAN FRANCISCO, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the acceptance of multiple abstracts for presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 11-15, 2026, in Boston, Massachusetts. Of note, new clinical data from both dose cohorts of the RIDGE-1...

Continue reading

Big Digital Energy, Inc. Announces Colocation Agreement with the Endeavor Group

Transaction Expected to Fill Capacity, Drive Near-Term Revenue Growth, and Increase Cash Flows; Demonstrate Management’s Commitment to Shareholders MIDLAND, Pa., April 27, 2026 (GLOBE NEWSWIRE) — Big Digital Energy, Inc. (“Big Digital” or the “Company”) (Nasdaq: MIGI; expected to change to “BGDE” on April 30, 2026), formerly known as Mawson Infrastructure Group Inc., today announced that it has entered into a strategic colocation agreement with an affiliate of the Endeavor Group (“Endeavor”). Endeavor consists of certain members of the Company’s management team. Under the terms of the agreement, Endeavor will purchase and deliver approximately 25,000 mining computers, and Big Digital will provide Endeavor with approximately 75MW of compute capacity. The Parties will operate under a 50%/50% profit-sharing arrangement whereby Big...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.